Fully Human Antibody Targeting Human CD19 For Cancer Therapeutic Development
Technology
E-013-2018
Patent ID
E-013-2018-0-JP-01
Country
JP
Application Type
DIV
Patent Status
Pending
Patent Number
Publication Number
2024-037918
Application Number
2023-212056
IC
NCI
Date Filed
Date Issued
Patent PDF